Latest Innovation And Technology News

Elevate Uranium Ltd reports steady progress on its U-pgrade demonstration plant and ongoing exploration drilling at Koppies and Marenica projects, alongside a 12% resource increase at the Bigrlyi Joint Venture and the appointment of a new chairman.

Aeeris Ltd delivered solid Q3 FY2025 results, driven by strong recurring revenue growth, a successful new product launch, and strategic moves to internalise key forecasting capabilities.

Aerometrex has appointed Robert Veitch as Acting CEO following Steve Masters' resignation, signaling a strategic push to accelerate revenue and profitability.

Micro-X Ltd has secured a $6 million contract extension from the U.S. Department of Homeland Security to develop and test additional self-screening airport security checkpoints, marking a significant step forward in its innovative security technology program.

De.mem Limited has secured a strategic distribution agreement with Singapore’s Firmbase Pte Ltd to penetrate key Asian markets, including China, Indonesia, and Japan, marking its first commercial sale in China’s burgeoning home water filtration sector.

Pure Hydrogen has handed over Australia’s first hydrogen fuel cell rear loader garbage truck to Solo Resource Recovery, marking a milestone in sustainable waste management and clean energy adoption.

PARKD Ltd has secured a 7-day extension to its exclusive licence agreement with Fielders Steel Roofing, following successful proof-of-concept projects for its Metal Deck Support System. The extension aims to finalise terms for a longer-term commercial partnership.

Ionic Rare Earths reports strong progress on its Belfast rare earth oxide recycling facility, backed by a robust feasibility study and UK government grant applications, alongside strategic developments in Brazil and Uganda.

Arovella Therapeutics has bolstered its financial position with a $20 million placement, fully funding the Phase 1 clinical trial of its lead CAR-iNKT therapy, ALA-101, targeting CD19-positive blood cancers. The company also established a Clinical Advisory Board and anticipates key regulatory and clinical milestones in 2025.

dorsaVi reported a modest 1.9% rise in sales revenue to $330k in Q2 FY25, launched its AI-powered Video AI movement analysis platform, and initiated a blockchain integration partnership to enhance data security.

BetMakers Technology Group reports a sharp 69% reduction in adjusted EBITDA loss and a 43% improvement in operating cash flow for Q2 FY25, marking a pivotal shift from restructuring to growth. The company’s successful Apollo platform migration and cost-cutting initiatives underpin a confident outlook for revenue expansion.

Vitrafy Life Sciences reports strong Q2 FY2025 progress, marked by a successful $35 million IPO, promising validation results in animal and human health, and strategic expansion into North America.